ArticleVaccine: X2024

Enhanced production of recombinant coxsackievirus A16 using a serum-free HEK293A suspension culture system for bivalent enterovirus vaccine development.

Yi-An Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.